Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial
PaperCitations, authors & open-access status
Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 140 citations, 2019 year and hybrid oa status.
140
Citations
2019
Year
hybrid
OA Status